BM

BMY

Bristol-Myers Squibb Company

NYSE
Market Cap
P/E Ratio
25.64
Dividend Yield
1.64%
Volume
52W High
52W Low
Avg Volume
52W Range

Financial Statements

What does this mean?

Income statement, balance sheet, and cash flow over time

Metric
No financial data available

Institutional Ownership

What does this mean?

Top institutions holding BMY

Institution Shares Held Value Date
Vanguard Group 150,000,000 $25,000,000,000 Oct 2025
BlackRock 140,000,000 $23,500,000,000 Nov 2025
State Street 80,000,000 $13,500,000,000 Oct 2025
Fidelity 65,000,000 $11,000,000,000 Nov 2025
Geode Capital 35,000,000 $5,900,000,000 Nov 2025

Top ETFs holding BMY

ETF Weight Shares
QQQ 8.50% 36,763,977
VGT 6.20% 7,840,499
SPY 4.50% 16,736,156
IVV 4.20% 24,186,114
VOO 3.80% 28,340,173

Frequently Asked Questions

Common questions about BMY

Bristol-Myers Squibb Company (BMY) is a publicly traded company listed on NYSE. Bristol-Myers Squibb Company (BMY) is included in the Stock Monitor database for research and watchlists. It operates in the Drug Manufacturers industry within the Healthcare sector.

The current stock price of BMY is $122.64, with a change of -2.36% in the latest session. Stock prices are updated during market hours and may be delayed.

Yes, BMY pays dividends with a current dividend yield of 1.64%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.

The P/E (Price-to-Earnings) ratio of BMY is 25.64. This relatively high P/E may indicate growth expectations or that the stock is trading at a premium. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

BMY has a market capitalization of $565.00 billion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

The 52-week trading range for BMY is $99.83 (low) to $155.02 (high). This range represents the lowest and highest prices the stock has traded at over the past year.

BMY belongs to the Healthcare sector specifically in the Drug Manufacturers industry. Understanding a company's sector helps investors compare it to peers and understand industry-specific trends that may affect performance.

Trade

Buy/Sell via broker links (affiliate).

Trading 212
Open Broker
Links may be affiliate links. Trading involves risk.

Paper Trade

Save a buy/sell to your portfolio tracker (not a real trade).

Sign in to save trades to your portfolio tracker.

Paper Orders

Limit/stop reminders, with optional bracket (take profit + stop loss).

Sign in to place paper orders.

Price Alerts

Notify when BMY crosses your target.

Sign in to create alerts and sync them across devices.

About

Bristol-Myers Squibb Company (BMY) is included in the Stock Monitor database for research and watchlists.

CEO
N/A
Industry
Drug Manufacturers
Sector
Healthcare
Employees
162,764
IPO Date
Jan 1, 2000

Analyst Ratings

What does this mean?
Piper Sandler
Dec 15, 2025
Hold
Goldman Sachs
Nov 23, 2025
Buy
Morgan Stanley
Nov 6, 2025
Buy
JPMorgan
Oct 20, 2025
Buy
Bernstein
Oct 3, 2025
Hold
Price Target
$123.87